Clinical Trials Logo

Healthy Subject clinical trials

View clinical trials related to Healthy Subject.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05117385 Recruiting - Healthy Subject Clinical Trials

The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune)

B-4-Immune
Start date: November 22, 2021
Phase: N/A
Study type: Interventional

This study will evaluate the capacity of botanical extracts to modulate immune mechanisms compared to a placebo group in healthy volunteers.

NCT ID: NCT04358315 Recruiting - Healthy Subject Clinical Trials

Consumer Assessment of Tobacco Flavor and Odor

Start date: April 3, 2023
Phase:
Study type: Observational

This trial studies consumer assessments of tobacco flavor and odor. This study will compare the ability of expert and consumer panels to identify and characterize flavors, determine threshold detection levels for individual and mixed flavors, and identify the dominant flavor of mixtures.

NCT ID: NCT04295096 Recruiting - Healthy Subject Clinical Trials

Collection of PBMCs From Healthy Subjects for the Development of Cellular Immunotherapy Product

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Title: Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy Subjects for the Development of Cellular Immunotherapy Product Background: CAR-T therapies are being developed that utilize modified immune cells to fight tumors. 'Off-the-shelf' allogeneic CAR-T technology has better efficacy and more promising clinical applications. Investigators want to use the cells of healthy subjects to perform the studies. To accomplish this, they are collecting PBMCs through apheresis. Objectives: To collect PBMCs from healthy subjects for product development for cell Immunotherapies.

NCT ID: NCT03897270 Recruiting - Breast Carcinoma Clinical Trials

Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

Start date: October 25, 2018
Phase: N/A
Study type: Interventional

This trial studies photoacoustic imaging of the breast in patients with breast cancer and healthy subjects. Dense breasts typically reduce the sensitivity of a mammography and also is associated with a higher risk of breast cancer. Photoacoustic tomography combines light and sound to provide more information about breast tissue.

NCT ID: NCT03386188 Recruiting - Healthy Subject Clinical Trials

Role of the Posterior Parietal Cortex in the Processing of Sensory Information

CORTEX
Start date: January 2016
Phase: N/A
Study type: Interventional

Although the primary motor cortex is considered has the common final pathway of motor commands, it is influenced by several structures as, for example, the premotor cortex and the posterior parietal cortex which are involved in motor planning and programming and which integrates movement-induced sensory impute (parieto-frontal circuits). Several studies have shown that there are some direct functional connections between the premotor cortex and the posterior parietal cortex and from these two regions to the primary motor cortex. The posterior parietal cortex can then be considered as a sensorimotor interface whose function in planification and motor control of upper limb is well demonstrated. The hypothesis is that the posterior parietal cortex could participate to the modulation of motor cortex excitability by proprioceptive sensory inputs namely long latency afferent inhibition and afferent induced facilitation.

NCT ID: NCT03207854 Recruiting - Malignant Neoplasm Clinical Trials

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

Start date: April 12, 2017
Phase:
Study type: Observational

This research trial collects and stores blood, tissue, and bone marrow specimens from patients with cancer or blood disorders, and healthy volunteers to study the immune system in a variety of different types of experiments, as well as associated clinical data as appropriate, focused on understanding mechanisms of immunotherapy.

NCT ID: NCT03188848 Recruiting - Healthy Subject Clinical Trials

Dose Escalating Study of BPI-3016 in Healthy Subjects

Start date: May 24, 2017
Phase: Phase 1
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, dose finding study evaluating the safety, pharmacokinetics and pharmacodynamics of subcutaneously injected BPI-3016 in Chinese healthy subjects.